Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EXAS Exact Sciences Corporation daily Stock Chart
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Medical Laboratories & Research | USA
statements
Index- P/E- EPS (ttm)-0.72 Insider Own0.70% Shs Outstand151.15M Perf Week-19.03%
Market Cap12.24B Forward P/E1722.34 EPS next Y0.05 Insider Trans-9.39% Shs Float145.48M Perf Month-11.07%
Income-84.00M PEG- EPS next Q-0.64 Inst Own90.60% Short Float10.00% Perf Quarter-0.48%
Sales876.30M P/S13.96 EPS this Y30.70% Inst Trans15.86% Short Ratio6.86 Perf Half Y-32.63%
Book/sh5.78 P/B14.01 EPS next Y113.50% ROA-12.90% Target Price123.64 Perf Year-11.04%
Cash/sh7.68 P/C10.54 EPS next 5Y- ROE-29.70% 52W Range75.35 - 123.99 Perf YTD-12.47%
Dividend- P/FCF- EPS past 5Y-15.80% ROI-11.60% 52W High-34.71% Beta1.55
Dividend %- Quick Ratio2.60 Sales past 5Y155.90% Gross Margin75.10% 52W Low7.43% ATR4.88
Employees1977 Current Ratio2.70 Sales Q/Q85.00% Oper. Margin-23.10% RSI (14)32.76 Volatility7.32% 4.36%
OptionableYes Debt/Eq1.09 EPS Q/Q15.60% Profit Margin-25.20% Rel Volume1.53 Prev Close80.82
ShortableYes LT Debt/Eq0.67 EarningsFeb 11 AMC Payout- Avg Volume2.12M Price80.95
Recom1.30 SMA20-14.51% SMA50-14.09% SMA200-19.36% Volume3,242,890 Change0.16%
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Sep-26-19Initiated Oppenheimer Outperform $130
Feb-26-19Upgrade Goldman Neutral → Buy $85 → $120
Oct-09-18Initiated UBS Buy
Sep-05-18Resumed The Benchmark Company Hold
Aug-13-18Reiterated Canaccord Genuity Buy $62 → $65
Apr-03-18Upgrade BTIG Research Neutral → Buy
Jan-29-18Initiated Goldman Neutral $51
Jan-08-18Reiterated The Benchmark Company Buy $60 → $65
Nov-13-17Downgrade Robert W. Baird Outperform → Neutral $56
Nov-01-17Downgrade BTIG Research Buy → Neutral
Oct-31-17Reiterated The Benchmark Company Buy $50 → $60
Oct-03-17Reiterated Canaccord Genuity Buy $45 → $60
Sep-21-17Reiterated Leerink Partners Outperform $45 → $50
Jul-26-17Reiterated Lake Street Hold $30 → $41
Feb-27-20 08:42AM  Genetic Test Gets Okayed by FDA: 4 Stocks to Keep an Eye On Zacks
Feb-25-20 08:28AM  The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement Benzinga -9.44%
Feb-24-20 10:39PM  Exact Sciences Announces Upsizing and Pricing of 0.3750% Convertible Senior Notes Due 2028 PR Newswire
04:01PM  Exact Sciences Announces Offering of $850 Million Convertible Senior Notes Due 2028 PR Newswire
Feb-19-20 05:44AM  Bull of the Day: Guardant Health (GH) Zacks
Feb-17-20 05:24AM  Edited Transcript of EXAS earnings conference call or presentation 11-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-12-20 03:52PM  Exact Sciences to acquire more biotech companies; plans to launch liver cancer test in 2020 American City Business Journals
09:18AM  The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga
08:56AM  Exact Sciences (EXAS) Q4 Earnings and Revenues Rise Y/Y Zacks
Feb-11-20 06:15PM  Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates Zacks
05:07PM  Exact Sciences beats income, revenue projections in 4Q earnings report American City Business Journals
04:05PM  Exact Sciences Announces Fourth-Quarter 2019 Results PR Newswire
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-04-20 06:41PM  Should Growth Investors Buy this Cancer Screening Biotech Stock? Zacks
12:30PM  Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
11:44AM  What's in the Cards for Exact Sciences' (EXAS) Q4 Earnings? Zacks
Feb-03-20 05:45PM  Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know Zacks
04:05PM  Eaton Vance Worldwide Health Sciences Fund Buys 3 Stocks in 4th Quarter GuruFocus.com
01:01PM  Exact Sciences doubled capital investment, job creation goal in Wisconsin, per report American City Business Journals
Jan-27-20 05:50PM  Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know Zacks
06:00AM  Exact Sciences schedules fourth-quarter, full-year 2019 earnings call PR Newswire
Jan-24-20 11:24AM  Exact Sciences, GameStop, Intel, Intuitive Surgical and Skyworks highlighted as Zacks Bull and Bear of the Day Zacks
09:55AM  What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings? Zacks
09:06AM  Can Critical Care Aid Edwards Lifesciences (EW) Q4 Earnings? Zacks
05:20AM  Bull of the Day: Exact Sciences (EXAS) Zacks
Jan-23-20 01:30PM  Exact Sciences' stock jumps after analysts question competitor's product American City Business Journals
10:45AM  Will New Buyouts Aid Quest Diagnostics (DGX) Q4 Earnings? Zacks
09:17AM  Will Segmental Growth Aid Hologic (HOLX) in Q1 Earnings? Zacks
08:23AM  What's in Store for Align Technology's (ALGN) Q4 Earnings? Zacks
Jan-22-20 07:30AM  Exact Sciences Gains After Rival's Colorectal Cancer Screening Product Falls Short TheStreet.com +10.55%
Jan-21-20 06:31AM  Is Exact Sciences Corporation (NASDAQ:EXAS) Trading At A 40% Discount? Simply Wall St.
Jan-20-20 09:13AM  Can Abbott (ABT) Q4 Earnings Ride on Growth in All Lines? Zacks
Jan-17-20 09:15AM  Another Milestone After Another Trade Deal Zacks
07:10AM  Exact Sciences (EXAS) Provides Q4 Expectations, Stock Falls Zacks
Jan-16-20 02:53PM  6 Guru Stocks With Negative Performances GuruFocus.com
09:52AM  Novavax Rises on Fast Track Designation to Influenza Vaccine Zacks
Jan-15-20 09:36AM  Perrigo (PRGO) Rises on Stellar Q419 Preliminary Results Zacks
Jan-14-20 01:44PM  Exact Sciences (EXAS) Stock Has 40% Upside From Here, Says Analyst TipRanks
04:41AM  Can Focus on High-Growth Area Up OrganiGram (OGI) Q1 Earnings? Zacks
Jan-13-20 01:51PM  Exact Sciences anticipates 2019 revenue over $876M, more than 1.6M completed Cologuard tests American City Business Journals -13.67%
11:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
10:17AM  All 4 of Analysts' Favorite Stocks Fell Last Year GuruFocus.com
10:16AM  Can New Strategic Efforts Aid Apharia's (APHA) Q2 Earnings? Zacks
09:13AM  Top Ranked Momentum Stocks to Buy for January 13th Zacks
08:14AM  Can Cannabis Therapy Drive Aphria's (APHA) Q2 Earnings? Zacks
Jan-12-20 07:00PM  Exact Sciences Announces Preliminary Fourth Quarter 2019 Results PR Newswire
Jan-07-20 10:08AM  Exact Sciences Rides on Cologuard, Eyes Merger Synergies Zacks
Jan-06-20 09:55AM  Walgreens Boots (WBA) to Post Q1 Earnings: What's in Store? Zacks
Jan-02-20 06:00AM  Exact Sciences to participate in J.P. Morgan Healthcare Conference PR Newswire
Dec-31-19 12:00AM  Bitcoins 9,000,000% Rise This Decade Leaves the Skeptics Aghast Bloomberg
Dec-26-19 12:05PM  EXACT Sciences Corporation (EXAS) vs. Top 20 Hedge Fund Stocks in 2019 Insider Monkey
Dec-25-19 07:17AM  3 Biotech Stocks to Buy as the Sector Heats Up TipRanks
Dec-24-19 11:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
Dec-17-19 11:33AM  Exact Sciences, Maker of the Cancer Test Cologuard, Is Vastly Undervalued, Analyst Says Barrons.com
Dec-16-19 06:53AM  Exact Sciences Corporation's (NASDAQ:EXAS) Path To Profitability Simply Wall St.
Dec-12-19 01:41PM  Theres more upside for biotech even after 24% gains in two months MarketWatch
06:00AM  New Evidence from Large Studies Highlights Value of Oncotype DX Breast Recurrence Score® to Guide Chemotherapy Treatment in Young Patients with Node-negative or Node-positive Early-stage Breast Cancer PR Newswire
Dec-04-19 08:35PM  Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS) Insider Monkey
04:30PM  Dr. David Ahlquist, co-inventor of Cologuard, named a Fellow of the National Academy of Inventors PR Newswire
Nov-18-19 10:17AM  Medtronic (MDT) to Report Q2 Earnings: What's in Store? Zacks
Nov-15-19 10:28AM  Why Cancer-Testing Specialist Exact Sciences Stock Is Up Today Barrons.com
Nov-10-19 06:55AM  If You Had Bought Exact Sciences (NASDAQ:EXAS) Shares Three Years Ago You'd Have Made 373% Simply Wall St.
Nov-08-19 12:22PM  Exact Sciences completes $2.8B acquisition of Genomic Health American City Business Journals
08:24AM  Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire
08:02AM  Exact Sciences Completes Combination with Genomic Health, Creating Leading Global Cancer Diagnostics Company PR Newswire
08:00AM  Exact Sciences Presents Data On Blood-Based Test For Detection Of Hepatocellular Carcinoma, Earns FDA Breakthrough Device Designation PR Newswire
Nov-07-19 01:55PM  Genomic Health Stockholders Approve Proposed Acquisition by Exact Sciences PR Newswire
Nov-05-19 09:29AM  Stocks That Would Have Made You Rich Today GOBankingRates
Nov-04-19 06:30PM  Shenandoah Telecommunications Set to Join S&P SmallCap 600 PR Newswire
Nov-01-19 06:00AM  Exact Sciences to participate in November investor conferences PR Newswire
Oct-31-19 06:53PM  Edited Transcript of EXAS earnings conference call or presentation 29-Oct-19 9:00pm GMT Thomson Reuters StreetEvents
Oct-30-19 07:01AM  The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings Benzinga -7.28%
Oct-29-19 06:25PM  Exact Sciences (EXAS) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:57PM  Genomic Health's longtime leader is leaving after $3 billion merger American City Business Journals
05:36PM  Exact Sciences beats Wall Street expectations with $218M in sales for 3Q American City Business Journals
04:05PM  Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million PR Newswire
04:05PM  Exact Sciences Presents New Stool-Based Colorectal Cancer Screening Performance Data, Initiates Prospective Screening Study PR Newswire
Oct-25-19 05:50PM  Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-24-19 09:30AM  Is Exact Sciences (EXAS) Stock Outpacing Its Medical Peers This Year? Zacks
Oct-21-19 11:39AM  Exact Sciences (EXAS) to Post Q3 Earnings: What's in Store? Zacks
Oct-18-19 05:45PM  Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know Zacks
Oct-17-19 10:57AM  Moore Kuehn, PLLC Encourages Genomic Health, Inc. and Carbonite, Inc. Investors to Contact Firm PR Newswire
Oct-16-19 07:10PM  Spiros Segalas' Top 5 Buys in the 3rd Quarter GuruFocus.com
Oct-14-19 06:00AM  Exact Sciences And Mayo Clinic Initiate 150,000 Patient, 7-Year Study To Evaluate Real-World Impact Of Cologuard® PR Newswire
Oct-11-19 12:53PM  Emergent's Chikungunya Vaccine Candidate Gets EMA's PRIME Tag Zacks
12:40PM  Seattle Genetics Begins Phase III Study on Tucatinib Combo Zacks
11:08AM  Do Hedge Funds Love EXACT Sciences Corporation (EXAS)? Insider Monkey
07:24AM  What Did Exact Sciences Corporation's (NASDAQ:EXAS) CEO Take Home Last Year? Simply Wall St.
Oct-10-19 11:17AM  bluebird Inks Genome Editing Research Deal With Novo Nordisk Zacks
11:15AM  Seattle Genetics Up More Than 20% in 3 Months: Here's Why Zacks
Oct-08-19 09:30AM  Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year? Zacks
06:00AM  Exact Sciences schedules third-quarter 2019 earnings call PR Newswire
Oct-04-19 10:09PM  Inside Genomic Health's $2.8B deal: A false start, rejections and a mysterious last-minute party American City Business Journals
Oct-03-19 12:46PM  Exact Sciences continues down strong growth path American City Business Journals +5.90%
Sep-26-19 10:51AM  3 Strong Buy Mid-Cap Stocks with High Upside TipRanks
Sep-25-19 09:18AM  Exact Sciences Corporation Enters Oversold Territory Zacks
Sep-24-19 11:19AM  Exact Sciences: Finding the Exact Price to Buy the Stock TheStreet.com
11:18AM  Cramer Weighs In On PayPal, NextEra And More Benzinga
09:10AM  Exact Sciences Gets FDA Nod for Label Expansion of Cologuard Zacks
Sep-23-19 04:15PM  How A New Approval Could Help This Biotech Stock Add $3 Billion In Sales Investor's Business Daily
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company offers Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Conroy Kevin TPresident and CEOFeb 27Sale80.2713,8751,113,746982,138Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 27Sale80.271,05184,36416,519Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27Sale80.271,627130,59956,116Feb 28 04:37 PM
Conroy Kevin TPresident and CEOFeb 26Option Exercise0.0029,3370996,013Feb 28 04:36 PM
Stenhouse MarkPresident, CologuardFeb 26Option Exercise0.003,262017,570Feb 28 04:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26Option Exercise0.003,436057,743Feb 28 04:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 25Sale85.114,910417,89054,307Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 25Sale85.1118,1151,541,768966,676Feb 26 05:11 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Option Exercise0.009,300059,217Feb 26 05:13 PM
Conroy Kevin TPresident and CEOFeb 24Option Exercise0.0034,3250984,791Feb 26 05:11 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Option Exercise35.7717,356620,77637,550Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 19Sale100.681,153116,0842,495Feb 20 05:55 PM
Cole G BradleyGeneral Manager - DiagnosticsFeb 19Sale100.0027,3562,735,60010,194Feb 21 04:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise0.003,64803,648Feb 20 05:55 PM
Cole G BradleyGeneral Manager - DiagnosticsJan 16Sale90.3010,000903,0008,653Jan 17 04:50 PM
Conroy Kevin TPresident and CEODec 16Option Exercise17.4811,440199,992950,466Dec 18 05:19 PM
Cole G BradleyGeneral Manager - DiagnosticsNov 21Sale80.3828,0162,251,92630,987Nov 25 05:18 PM
Johnson Scott C.SVP - Research and DevelopmentSep 12Sale108.633,527383,13812,311Sep 13 04:52 PM
Johnson Scott C.SVP - Research and DevelopmentSep 11Option Exercise0.007,500015,838Sep 13 04:52 PM
LEVANGIE DANIEL JDirectorJul 31Option Exercise5.3142,607226,42155,065Aug 02 04:24 PM
WYZGA MICHAEL SDirectorJul 31Option Exercise26.982,50067,45013,913Aug 02 04:25 PM
LEVANGIE DANIEL JDirectorJul 31Sale117.6442,6075,012,39812,458Aug 02 04:24 PM
Zanotti Katherine SDirectorJul 31Sale117.931,744205,67077,513Aug 02 04:28 PM
WYZGA MICHAEL SDirectorJul 31Sale117.935,000589,6508,913Aug 02 04:25 PM
Doyle James EdwardDirectorJul 31Sale117.932,808331,14734,440Aug 02 04:22 PM
Carey Thomas D.DirectorJul 31Sale117.6510,0001,176,48734,181Aug 02 04:20 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 30Sale105.609,8451,039,63249,917Jul 31 05:57 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Option Exercise0.0018,750059,762Jul 31 05:57 PM
Stenhouse MarkPresident, CologuardApr 03Sale92.5411,1921,035,69614,308Apr 04 04:24 PM
Stenhouse MarkPresident, CologuardApr 02Option Exercise0.0025,000025,500Apr 04 04:24 PM
COWARD D SCOTTChief Administrative OfficerMar 11Sale87.212,774241,926103,096Mar 12 05:19 PM
Conroy Kevin TPresident and CEOMar 11Sale87.2111,227979,129938,526Mar 12 05:16 PM
COWARD D SCOTTChief Administrative OfficerMar 09Option Exercise0.006,0250105,870Mar 12 05:19 PM
Conroy Kevin TPresident and CEOMar 09Option Exercise0.0024,4000949,753Mar 12 05:16 PM
open in yahoo | open in reuters | open in google